Benaroya Research Institute is committed to fighting the more than 80 autoimmune diseases.
BRI is waging a comprehensive fight against rheumatoid arthritis.
Scientists at BRI recently discovered a critical pathway in peanut allergy that may extend to other food allergies.
For years, BRI has had its sights set on helping these patients living with allergies or asthma breathe easier. And our efforts just got a huge and welcome boost.
A critical factor in whether people develop an autoimmune disease is “cell communication.”
BRI scientists have created a model system of the human lung in a laboratory dish that replicates the environment of a lung.
TrialNet is working to change type 1 diabetes diagnosis with a new T1D staging classification system.
Scientists at BRI continue to look for better drugs and therapies as well as ways to eliminate multiple sclerosis.
BRI scientists have learned there are multitudes of different immune system cell types, and few are exactly alike.
Over the last few years, several unique and pioneering technologies at BRI have been combined to create a “pipeline” approach to find and study rare disease-associated cells.
© 2022 Benaroya Research Institute | 1201 Ninth Avenue, Seattle, WA 98101-2795